About this trial
The objective of this study to evaluate the safety and effectiveness of the Castor single branch stent graft for endovascular repair of acute aortic syndrome patients without an inadequate proximal landing zone (\<15mm)
Eligibility criteria
Qualifiers
Patients with acute Stanford type B aortic syndrome who received thoracic endovascular aortic repair by meant of Castor single branch stent graft from June 2018 to June 2022
Disqualifiers
Patients with acute type B aortic syndrome with an adequate proximal landing zone (≥15mm)
Previous endovascular repair of the aorta
Patients with missing data and loss of follow-up
Trial design
Treatments tested in this trial
- the Castor single branch stent graft
Treatment groups
Sponsors and collaborators
First Affiliated Hospital Xi'an Jiaotong University
Lead sponsor
Hanzhong Central Hospital
Collaborator
Affiliated Hospital of Gansu Medical College
Collaborator
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
Collaborator
Xianyang Hospital of Yan'an University
Collaborator
Baoji Central Hospital
Collaborator
General Hospital of Ningxia Medical University
Collaborator
People's Hospital of Ningxia Hui Autonomous Region
Collaborator
Qinghai Red Cross Hospital
Collaborator
Hanzhong People's Hospital
Collaborator